1. Home
  2. BOLT vs ARTW Comparison

BOLT vs ARTW Comparison

Compare BOLT & ARTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • ARTW
  • Stock Information
  • Founded
  • BOLT 2015
  • ARTW 1956
  • Country
  • BOLT United States
  • ARTW United States
  • Employees
  • BOLT N/A
  • ARTW N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • ARTW Industrial Machinery/Components
  • Sector
  • BOLT Health Care
  • ARTW Industrials
  • Exchange
  • BOLT Nasdaq
  • ARTW Nasdaq
  • Market Cap
  • BOLT 16.8M
  • ARTW 17.2M
  • IPO Year
  • BOLT 2021
  • ARTW N/A
  • Fundamental
  • Price
  • BOLT $5.50
  • ARTW $4.26
  • Analyst Decision
  • BOLT Buy
  • ARTW
  • Analyst Count
  • BOLT 3
  • ARTW 0
  • Target Price
  • BOLT $50.00
  • ARTW N/A
  • AVG Volume (30 Days)
  • BOLT 16.5K
  • ARTW 80.1K
  • Earning Date
  • BOLT 08-19-2025
  • ARTW 10-03-2025
  • Dividend Yield
  • BOLT N/A
  • ARTW N/A
  • EPS Growth
  • BOLT N/A
  • ARTW N/A
  • EPS
  • BOLT N/A
  • ARTW 0.44
  • Revenue
  • BOLT $3,638,000.00
  • ARTW $23,523,353.00
  • Revenue This Year
  • BOLT N/A
  • ARTW N/A
  • Revenue Next Year
  • BOLT $13.62
  • ARTW N/A
  • P/E Ratio
  • BOLT N/A
  • ARTW $12.20
  • Revenue Growth
  • BOLT N/A
  • ARTW N/A
  • 52 Week Low
  • BOLT $5.20
  • ARTW $1.43
  • 52 Week High
  • BOLT $14.36
  • ARTW $4.69
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 40.87
  • ARTW 75.31
  • Support Level
  • BOLT $5.30
  • ARTW $3.45
  • Resistance Level
  • BOLT $5.94
  • ARTW $4.18
  • Average True Range (ATR)
  • BOLT 0.31
  • ARTW 0.35
  • MACD
  • BOLT -0.04
  • ARTW 0.09
  • Stochastic Oscillator
  • BOLT 13.34
  • ARTW 79.91

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

Share on Social Networks: